Blue Fin Capital’s PetMed Express PETS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-8,015
Closed -$325K 131
2017
Q2
$325K Sell
8,015
-1,985
-20% -$61.5K 0.21% 106
2017
Q1
$201K Sell
10,000
-4,500
-31% -$95.2K 0.12% 133
2016
Q4
$334K Buy
14,500
+1,745
+14% +$37.4K 0.22% 105
2016
Q3
$259K Hold
12,755
0.21% 105
2016
Q2
$239K Hold
12,755
0.2% 110
2016
Q1
$228K Sell
12,755
-1,745
-12% -$29.9K 0.19% 107
2015
Q4
$249K Buy
14,500
+435
+3% +$7.31K 0.19% 109
2015
Q3
$226K Buy
14,065
+275
+2% +$4.61K 0.18% 118
2015
Q2
$238K Hold
13,790
0.17% 123
2015
Q1
$228K Hold
13,790
0.16% 127
2014
Q4
$198K Buy
13,790
+275
+2% +$3.7K 0.15% 130
2014
Q3
$184K Buy
13,515
+2,800
+26% +$39K 0.15% 124
2014
Q2
$144K Buy
+10,715
New +$141K 0.12% 128

Other funds holding PETS

Blue Fin Capital's PETS Position: Q3 2017 in Review

Blue Fin Capital sold out of PetMed Express (PETS) in Q3 2017, closing a stake of 8,015 shares — an estimated $325K sold.

Blue Fin Capital first reported a position in PETS in Q2 2014 and held it in 13 quarters. The position peaked at $334K in Q4 2016. 179 funds tracked by Wall St. Rank hold PETS as of Q3 2017.

  • Blue Fin Capital reported no remaining PetMed Express position as of Q3 2017 after selling out during the quarter.
  • Blue Fin Capital sold 8,015 PetMed Express shares in Q3 2017, an estimated $325K.
  • Blue Fin Capital first reported a position in PetMed Express in Q2 2014 and held it in 13 quarters.
  • Blue Fin Capital's PetMed Express position peaked at $334K in Q4 2016.
  • 179 funds tracked by Wall St. Rank held PetMed Express as of Q3 2017.

Based on Blue Fin Capital's 13F filing for Q3 2017, filed 11 Oct 2017.